Featured
-
-
Perspective |
Biology and evolution of poorly differentiated neuroendocrine tumors
Rubin and colleagues discuss the origin and evolution of poorly differentiated neuroendocrine tumors, and highlight potential new therapeutic strategies.
- David S Rickman
- , Himisha Beltran
- & Mark A Rubin
-
Letter |
A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease
Inhibition of Hsp90 as its C-terminus allows for the mature folding of GR and its full activity, thus ameliorating Cushing symptoms in a mouse model.
- Mathias Riebold
- , Christian Kozany
- & Marcelo Paez-Pereda